Understanding and Improving Respiratory Succinate Production from Glycerol by Actinobacillus Succinogenes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Construction and Enzymatic Characterization of E
1 Minimizing acetate formation in E. coli fermentations 2 Marjan De Mey*, Sofie De Maeseneire, Wim Soetaert and Erick Vandamme 3 Ghent University, Laboratory of Industrial Microbiology and Biocatalysis, Department of 4 Biochemical and Microbial Technology, Faculty of Bioscience Engineering, Coupure links 5 653, B-9000 Ghent, Belgium 6 7 * Correspondence address: Marjan De Mey 8 Laboratory of Industrial Microbiology and Biocatalysis 9 Department of Biochemical and Microbial Technology 10 Faculty of Bioscience Engineering 11 Ghent University 12 Coupure links 653 13 B-9000 Gent 14 Tel: +32-9-264-60-28 15 Fax: +32-9-264-62-31 16 [email protected] 17 Keywords: acetate reduction, Escherichia coli, metabolic engineering 1 18 Abstract 19 Escherichia coli remains the best established production organisms in industrial 20 biotechnology. However, during aerobic fermentation runs at high growth rates, considerable 21 amounts of acetate are accumulated as by-product. This by-product has negative effects on 22 growth and protein production. Over the last 20 years, substantial research efforts have been 23 spent to reduce acetate accumulation during aerobic growth of E. coli on glucose. From the 24 onset it was clear that this quest should not be a simple nor uncomplicated one. Simple 25 deletion of the acetate pathway, reduced the acetate accumulation, but instead other by- 26 products were formed. This minireview gives a clear outline of these research efforts and the 27 outcome of them, including bioprocess level approaches and genetic approaches. Recently, 28 the latter seems to have some promising results. 29 30 1 Introduction 31 Escherichia coli was the first and is still one of the most commonly used production 32 organisms in industrial biotechnology. -
Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance Naoki Kumashiro,1,2 Sara A
ORIGINAL ARTICLE Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance Naoki Kumashiro,1,2 Sara A. Beddow,3 Daniel F. Vatner,2 Sachin K. Majumdar,2 Jennifer L. Cantley,1,2 Fitsum Guebre-Egziabher,2 Ioana Fat,2 Blas Guigni,2 Michael J. Jurczak,2 Andreas L. Birkenfeld,2 Mario Kahn,2 Bryce K. Perler,2 Michelle A. Puchowicz,4 Vara Prasad Manchem,5 Sanjay Bhanot,5 Christopher D. Still,6 Glenn S. Gerhard,6 Kitt Falk Petersen,2 Gary W. Cline,2 Gerald I. Shulman,1,2,7 and Varman T. Samuel2,3 – We measured the mRNA and protein expression of the key transcriptional factors and cofactors (8 12). Yet, despite gluconeogenic enzymes in human liver biopsy specimens and the high degree of transcription regulation for these found that only hepatic pyruvate carboxylase protein levels enzymes, the control they exert over gluconeogenic flux is related strongly with glycemia. We assessed the role of pyruvate relatively weak (13–16). We recently reported that hepatic carboxylase in regulating glucose and lipid metabolism in rats expression of PEPCK and G6PC mRNA was not related to through a loss-of-function approach using a specific antisense fasting hyperglycemia in two rodent models of type 2 di- oligonucleotide (ASO) to decrease expression predominantly in abetes and in patients with type 2 diabetes (17). Thus, we liver and adipose tissue. Pyruvate carboxylase ASO reduced hypothesized that other mechanisms must account for in- plasma glucose concentrations and the rate of endogenous glucose production in vivo. Interestingly, pyruvate carboxylase ASO also creased hepatic gluconeogenesis and fasting hyperglycemia reduced adiposity, plasma lipid concentrations, and hepatic in type 2 diabetes. -
Glycerol Dehydrogenase from Gluconobacter Industrius
Agric. Biol Chem., 49 (4), 1001 -1010, 1985 1001 Solubilization, Purification and Properties of Membrane-bound Glycerol Dehydrogenase from Gluconobacter industrius Minoru Ameyama,Emiko Shinagawa, Kazunobu Matsushita and Osao Adachi Laboratory of Applied Microbiology, Department of Agricultural Chemistry, Faculty of Agriculture, Yamaguchi University, Yamaguchi 753, Japan Received July 30, 1984 Membrane-bound glycerol dehydrogenase was solubilized and purified about 100-fold from the membraneof Gluconobacter industrius IFO 3260 grown on a glycerol-glutamate medium. Solubilization of the enzyme was successfully achieved by use of 0.5% dimethyldodecylamineoxide in 0.05 m Tris-HCl, pH 8.0. Alcohol dehydrogenase and D-glucose dehydrogenase, which were abundantly formed in the same bacterial membrane, were eliminated on solubilization. Glycerol dehydrogenase was further purified through fractionation with polyethylene glycol 6000. The enzymeshowed a broad substrate specificity and various kinds of polyhydroxyl alcohols, in addition to glycerol, were rapidly oxidized in the presence of 2,6-dichlorophenolindophenoi and phenazine methosulfate as the electron acceptor but NADand NADPwere inert. The enzyme was proved to be a quinoprotein in which pyrroloquinoline quinone functioned as the prosthetic group. The first report on microbial oxidation of localization of the oxidase system in cells of G. glycerol to dihydroxyacetone was by Bertrand liquefaciens and found that the oxidation of with a strain capable of L-sorbose fermen- glycerol and raeso-erythritol -
Citric Acid Cycle
CHEM464 / Medh, J.D. The Citric Acid Cycle Citric Acid Cycle: Central Role in Catabolism • Stage II of catabolism involves the conversion of carbohydrates, fats and aminoacids into acetylCoA • In aerobic organisms, citric acid cycle makes up the final stage of catabolism when acetyl CoA is completely oxidized to CO2. • Also called Krebs cycle or tricarboxylic acid (TCA) cycle. • It is a central integrative pathway that harvests chemical energy from biological fuel in the form of electrons in NADH and FADH2 (oxidation is loss of electrons). • NADH and FADH2 transfer electrons via the electron transport chain to final electron acceptor, O2, to form H2O. Entry of Pyruvate into the TCA cycle • Pyruvate is formed in the cytosol as a product of glycolysis • For entry into the TCA cycle, it has to be converted to Acetyl CoA. • Oxidation of pyruvate to acetyl CoA is catalyzed by the pyruvate dehydrogenase complex in the mitochondria • Mitochondria consist of inner and outer membranes and the matrix • Enzymes of the PDH complex and the TCA cycle (except succinate dehydrogenase) are in the matrix • Pyruvate translocase is an antiporter present in the inner mitochondrial membrane that allows entry of a molecule of pyruvate in exchange for a hydroxide ion. 1 CHEM464 / Medh, J.D. The Citric Acid Cycle The Pyruvate Dehydrogenase (PDH) complex • The PDH complex consists of 3 enzymes. They are: pyruvate dehydrogenase (E1), Dihydrolipoyl transacetylase (E2) and dihydrolipoyl dehydrogenase (E3). • It has 5 cofactors: CoASH, NAD+, lipoamide, TPP and FAD. CoASH and NAD+ participate stoichiometrically in the reaction, the other 3 cofactors have catalytic functions. -
<I>Lactobacillus Reuteri</I>
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Faculty Publications in Food Science and Food Science and Technology Department Technology 2014 From prediction to function using evolutionary genomics: Human-specific ecotypes of Lactobacillus reuteri have diverse probiotic functions Jennifer K. Spinler Texas Children’s Hospital, [email protected] Amrita Sontakke Baylor College of Medicine Emily B. Hollister Baylor College of Medicine Susan F. Venable Baylor College of Medicine Phaik Lyn Oh University of Nebraska, Lincoln See next page for additional authors Follow this and additional works at: http://digitalcommons.unl.edu/foodsciefacpub Spinler, Jennifer K.; Sontakke, Amrita; Hollister, Emily B.; Venable, Susan F.; Oh, Phaik Lyn; Balderas, Miriam A.; Saulnier, Delphine M.A.; Mistretta, Toni-Ann; Devaraj, Sridevi; Walter, Jens; Versalovic, James; and Highlander, Sarah K., "From prediction to function using evolutionary genomics: Human-specific ce otypes of Lactobacillus reuteri have diverse probiotic functions" (2014). Faculty Publications in Food Science and Technology. 132. http://digitalcommons.unl.edu/foodsciefacpub/132 This Article is brought to you for free and open access by the Food Science and Technology Department at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications in Food Science and Technology by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Authors Jennifer K. Spinler, Amrita Sontakke, Emily B. Hollister, -
Mechanism F Formation of Oxaloacetate and Phosphoenol Pyruvate from Pyruvate1
THE JOURNAL OF VITAMINOLOGY 14, 59-67 (1968) MECHANISM F FORMATION OF OXALOACETATE AND PHOSPHOENOL PYRUVATE FROM PYRUVATE1 HARLAND G. WOOD Department of Biochemistry, Case Western Reserve University Cleveland, Ohio 44, 106, U.S.A. Pyruvate, oxaloacetate and P-enolpyruvate have been known to be key compounds in metabolism for many years; pyruvate since 1911 when Neuberg found that yeast decarboxylates pyruvate to acetaldehyde, oxaloacetate since 1937 when Krebs pro posed the citric acid cycle, and P-enolpyruvate since 1934-1936 when Lohmann, Meyerhof and Kiessling discovered that 3-phosphoglycerate is converted to P enolpyruvate by dialyzed yeast or muscle extracts. These three compounds are the hub of numerous reactions leading to both synthesis and breakdown of carbo hydrates, fats and nitrogenous compounds (See the recent review by Utter (1) ). Furthermore, they are interlocked within themselves by a series of reactions re sulting in the synthesis of each fromn the other with accompanying breakdown of the companion compound. There has been a long debate concerning the mechanism of formation of P enolpyruvate from pyruvate. The conversion of P-enolpyruvate to pyruvate in glycolysis by pyruvate kinase was shown by Lardy and Ziegler (2) in 1945 to be reversible, but the equilibrium lies far to the right and the physiological signi ficance of the reversibility is questionable. The possibility that P-enolpyruvate might be formed by a pathway other than via pyruvate kinase was first raised by Kalckar (3) who found that kidney preparations could form P-enolpyruvate from malate and fumarate. At that time Wood and Werkman had discovered fixation of CO2 by heterotrophs and had postulated that the fixation occurs by combination of CO2 with pyruvate to give oxaloacetate. -
Pyruvate Carboxylase Signalling Axis Couples Mitochondrial Metabolism to Glucose-Stimulated Insulin Secretion in Pancreatic B-Cells
ARTICLE Received 23 Oct 2015 | Accepted 26 Apr 2016 | Published 6 Jun 2016 DOI: 10.1038/ncomms11740 OPEN The MDM2–p53–pyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic b-cells Xiaomu Li1,2,3,*, Kenneth K.Y. Cheng1,2,*, Zhuohao Liu1,2, Jin-Kui Yang4, Baile Wang1,2, Xue Jiang1,2, Yawen Zhou1,2, Philip Hallenborg5, Ruby L.C. Hoo1,2, Karen S.L. Lam1,2, Yasuhiro Ikeda6, Xin Gao3 & Aimin Xu1,2,7 Mitochondrial metabolism is pivotal for glucose-stimulated insulin secretion (GSIS) in pancreatic b-cells. However, little is known about the molecular machinery that controls the homeostasis of intermediary metabolites in mitochondria. Here we show that the activation of p53 in b-cells, by genetic deletion or pharmacological inhibition of its negative regulator MDM2, impairs GSIS, leading to glucose intolerance in mice. Mechanistically, p53 activation represses the expression of the mitochondrial enzyme pyruvate carboxylase (PC), resulting in diminished production of the TCA cycle intermediates oxaloacetate and NADPH, and impaired oxygen consumption. The defective GSIS and mitochondrial metabolism in MDM2-null islets can be rescued by restoring PC expression. Under diabetogenic conditions, MDM2 and p53 are upregulated, whereas PC is reduced in mouse b-cells. Pharmacological inhibition of p53 alleviates defective GSIS in diabetic islets by restoring PC expression. Thus, the MDM2–p53–PC signalling axis links mitochondrial metabolism to insulin secretion and glucose homeostasis, and could represent a therapeutic target in diabetes. 1 State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pok Fu Lam, Hong Kong. 2 Department of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong. -
Pyruvate Carboxylase and Phosphoenolpyruvate Carboxykinase Activity in Leukocytes and Fibroblasts from a Patient with Pyruvate Carboxylase Deficiency
Pediat. Res. 13: 3843 (1979) Citrate synthase lymphocytes fibroblasts phosphoenol pyruvate carboxykinase lactic acidosis pyruvate carboxylase pyruvate carboxylase deficiency Pyruvate Carboxylase and Phosphoenolpyruvate Carboxykinase Activity in Leukocytes and Fibroblasts from a Patient with Pyruvate Carboxylase Deficiency Division of Genetics and Departmenr of Pediatrics, Universiy of Oregon Health Sciences Center, Porrland, Oregon; and Department of Biochemistry, School of Medicine, Case Western Reserve Universi!,., Cleveland, Ohio, USA Summary complex (PDC) (7, 13, 32, 35), and PEPCK (14, 17,40). With the exception of PDC which catalyzes the first step in the Krebs cycle, Normal values are given for the activities of pyruvate carbox- the enzymes are necessary for gluconeogenesis in mammalian ylase (E.C. 6.4.1.1), mitochondrial phosphoenolpyruvate carboxy- renal cortex and liver. In addition to its gluconeogenic role. base (E.C. 4.1.1.32, PEPCK), and citrate synthase (E.C. 4.1.3.7) pyruvate carboxylase is required for the adequate operation of the in fibroblasts, lymphocytes, and leukocytes. Also given are values Krebs cycle because of its role in the replenishment of four-carbon for these enzymes in the leukocytes and fibroblasts from a severely Krebs cycle intermediates. Both the kitochondrial and cytosolic mentally and developmentally retarded patient with proximal renal forms of PEPCK are present in human liver. tubular acidosis and hepatic, cerebral, and renal cortical pyruvate Fructose 1,6-bisphosphatase (28) and PDC deficiency (7) have carboxylase deficiency. In normals, virtually all of the mitochon- been diagnosed in leukocytes and, although there are references drial PEPCK and pyruvate carboxylase activity was present in the to the presence of pyruvate carboxylase in fibroblasts (3. -
Medium and Long-Term Opportunities and Risks of the Biotechnological Production of Bulk Chemicals from Renewable Resources
Medium and Long-term Opportunities and Risks of the Biotechnological Production of Bulk Chemicals from Renewable Resources - The Potential of White Biotechnology The BREW Project Final report Prepared under the European Commission’s GROWTH Programme (DG Research) Project team: Academy Utrecht University (UU), Dept. of Science, Technology and Society (STS), Utrecht, Netherlands Fraunhofer Institute for Systems and Innovation Research (FhG-ISI), Karlsruhe, Germany Universidad Complutense de Madrid (UCM), Dept. of Chemical Engineering, Madrid, Spain Plant Research International (PRI), Wageningen, Netherlands CERISS (Centro per l'Educazione, la Ricerca, l'Informazione su Scienza e Società), Milan, Italy A&F (Agrotechnology and Food Innovations) Wageningen, Netherlands Industry partners BP Chemicals, Hull, United Kingdom Degussa AG, Hanau, Germany DSM NV, Heerlen, Netherlands DuPont, Bad Homburg, Germany NatureWorks, Naarden, Netherlands Novozymes A/S, Bagsvaerd, Denmark Roquette Frères, Lestrem, France Shell International Chemicals BV, Amsterdam, Netherlands Uniqema, Wilton/Redcar, United Kingdom Utrecht, September 2006 Authors Dr. Martin Patel (project co-ordinator) Utrecht University (UU) Manuela Crank, BE Chem Department of Science, Technology Dr. Veronika Dornburg and Society (STS) Barbara Hermann, M.Sc. Heidelberglaan 2 Lex Roes, M.Sc. NL-3584 CS Utrecht, Netherlands Tel. +31 (0) 30 253-7600 Fax +31 (0) 30 253-7601 [email protected] Dr. Bärbel Hüsing Fraunhofer Institute for Systems and Innovation Research (FhG-ISI), Karlsruhe, Germany Dr. Leo Overbeek Plant Research International (PRI) Wageningen, Netherlands Dr. Fabio Terragni CERISS (Centro per l'Educazione, la Dr. Elena Recchia Ricerca, l'Informazione su Scienza e Società), Milan, Italy Contributors Academy Dr. Ruud Weusthuis A&F (Agrotechnology and Food Innovations) Wageningen, Netherlands Prof. -
Evolution of Coenzyme BI2 Synthesis Among Enteric Bacteria
Copyright 0 1996 by the Genetics Society of America Evolution of Coenzyme BI2Synthesis Among Enteric Bacteria: Evidence for Loss and Reacquisition of a Multigene Complex Jeffrey G. Lawrence and John R. Roth Department of Biology, University of Utah, Salt Lake City, Utah 84112 Manuscript received June 16, 1995 Accepted for publication October 4, 1995 ABSTRACT We have examined the distribution of cobalamin (coenzyme BI2) synthetic ability and cobalamin- dependent metabolism among entericbacteria. Most species of enteric bacteria tested synthesize cobala- min under both aerobic and anaerobic conditions and ferment glycerol in a cobalamindependent fashion. The group of species including Escha'chia coli and Salmonella typhimurium cannot ferment glyc- erol. E. coli strains cannot synthesize cobalamin de novo, and Salmonella spp. synthesize cobalamin only under anaerobic conditions. In addition, the cobalamin synthetic genes of Salmonella spp. (cob) show a regulatory pattern different from that of other enteric taxa tested. We propose that the cobalamin synthetic genes, as well asgenes providing cobalamindependent diol dehydratase, were lostby a common ancestor of E. coli and Salmonella spp. and were reintroduced as a single fragment into the Salmonella lineage from an exogenous source. Consistent with this hypothesis, the S. typhimurium cob genes do not hybridize with the genomes of other enteric species. The Salmonella cob operon may represent a class of genes characterized by periodic loss and reacquisition by host genomes. This process may be an important aspect of bacterial population genetics and evolution. OBALAMIN (coenzyme BIZ) is a large evolution- The cobalamin biosynthetic genes have been charac- C arily ancient molecule ( GEORGOPAPADAKOUand terized in S. -
High-Yield Anaerobic Succinate Production by Strategically
Meng et al. Microb Cell Fact (2016) 15:141 DOI 10.1186/s12934-016-0536-1 Microbial Cell Factories RESEARCH Open Access High‑yield anaerobic succinate production by strategically regulating multiple metabolic pathways based on stoichiometric maximum in Escherichia coli Jiao Meng1,2,3†, Baiyun Wang1,2,3†, Dingyu Liu1,2,3, Tao Chen1,2,3,4, Zhiwen Wang1,2,3* and Xueming Zhao1,2,3 Abstract Background: Succinate has been identified by the U.S. Department of Energy as one of the top 12 building block chemicals, which can be used as a specialty chemical in the agricultural, food, and pharmaceutical industries. Escheri- chia coli are now one of the most important succinate producing candidates. However, the stoichiometric maximum succinate yield under anaerobic conditions through the reductive branch of the TCA cycle is restricted by NADH sup- ply in E. coli. Results: In the present work, we report a rational approach to increase succinate yield by regulating NADH supply via pentose phosphate (PP) pathway and enhancing flux towards succinate. The deregulated genes zwf243 (encod- ing glucose-6-phosphate dehydrogenase) and gnd361 (encoding 6-phosphogluconate dehydrogenase) involved in NADPH generation from Corynebacterium glutamicum were firstly introduced into E. coli for succinate production. Co-expression of beneficial mutated dehydrogenases, which removed feedback inhibition in the oxidative part of the PP pathway, increased succinate yield from 1.01 to 1.16 mol/mol glucose. Three critical genes, pgl (encoding 6-phos- phogluconolactonase), tktA (encoding transketolase) and talB (encoding transaldolase) were then overexpressed to redirect more carbon flux towards PP pathway and further improved succinate yield to 1.21 mol/mol glucose. -
The Diversity of Microbial Aldo/Keto Reductases from Escherichia Coli K12
Lapthorn, A. J., Zhu, X., and Ellis, E. M. (2013) The diversity of microbial aldo/keto reductases from Escherichia coli K12. Chemico-Biological Interactions, 202(1-3), pp. 168-177. (doi:10.1016/j.cbi.2012.10.008) There may be differences between this version and the published version. You are advised to consult the publisher’s version if you wish to cite from it. http://eprints.gla.ac.uk/124204/ Deposited on: 07 October 2016 Enlighten – Research publications by members of the University of Glasgow http://eprints.gla.ac.uk The diversity of microbial aldo/keto reductases from Escherichia coli K12 Adrian J. Lapthorn 1, Xiaofeng Zhu 2,3 and Elizabeth M. Ellis 3 1 School of Chemistry, Joseph Black Building, University of Glasgow, Glasgow G12 8QQ 2 College of Life Science and State Key Laboratory of Biotherapy and Cancer Centre, Sichuan University, Chengdu, China 3 Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, Glasgow, G4 0RE Corresponding author: Adrian J. Lapthorn School of Chemistry, Joseph Black Building, University of Glasgow, Glasgow G12 8QQ Tel: +44 141-330 5940 Fax: +44 141-330 4888 E-mail: [email protected] Key Words: Aldo-Keto reductases, methylglyoxal reductase, 2,5-diketo-D-gluconate reductase, tyrosine auxotrophy suppressor protein, L-glyceraldehyde 3-phosphate reductase, AKR quaternary structure. Abstract The genome of Escherichia coli K12 contains 9 open reading frames encoding aldo/keto reductases (AKR) that are differentially regulated and sequence diverse. A significant amount of data is available for the E. coli AKRs through the availability of gene knockouts and gene expression studies, which adds to the biochemical and kinetic data.